Aimmune Therapeutics Inc (AIMT) Is Bringing A 100 Year Old Treatment Into The 21st Century

Aimmune Therapeutics Inc (NASDAQ:AIMT) just updated us as to the progress of its ongoing pivotal in peanut allergy, and suggested that enrollment will...

Keep Reading →